查詢結果分析
來源資料
頁籤選單縮合
題名 | 中醫藥研究成果推動與應用=Chinese Medicine Research Results Promotion and Application |
---|---|
作者 | 顏上詠; | 書刊名 | 中醫藥年報 |
卷期 | 3 2014.12[民103.12] |
頁次 | 頁(28)1-(28)19 |
分類號 | 413 |
關鍵詞 | 中醫藥; 專利; 智慧財產; 技術授權; Chinese medicine; Patent; Intellectual property righ; |
語文 | 中文(Chinese) |
中文摘要 | 研究目的:中醫藥委員會研究計畫具有良好的成果,希望藉由本計畫,不但可以評估現有的研究成果,從中篩選出好的案件以專利保護,並以積極行動推展中醫藥委員會委辦研究計畫之優良成果,並加速研究成果之應用及促進產業發展。另一方面提供專利及富智財文化經驗團隊組成諮詢團隊,提供相關諮詢服務。 研究方法:協助中醫藥委員會評估及申請專利,另將中醫藥委員會已獲得之專利或優良研究成果,舉辦三場公開技轉及成果應用說明會,邀請各家藥廠及生技公司、學術界等相關單位參與,徵求有意願承接及合作的廠商以落實學術成果產業化,期間並配合辦理中醫藥智慧財產權相關課程訓練。撰寫招商、技轉授權與契約書相關資料,進行專利或優良研究成果授權。成立諮詢委員會,供中醫藥委員會及本會委託研究計畫主持人諮詢。 結果:專利評估會議共舉辦四場,評估的案件共 22件,其中只有 3件,符合專利要件,建議先申請台灣專利,可以在優先權取得先機,未來一年內,若有需要也可以以台灣專利申請的優先權再申請他國專利。公開技轉及成果應用說明會(含技轉說明會及智權課程),共吸引 240人次參與,會議之後也都有非常熱烈的討論及意見交換。 討論:評估的案件,原計畫為 20件,而本次評估的案件 22件(多年計畫視為同一件),惟符合申請專利的案件,因為技術缺乏新穎性及進步性居多,所以未來在技術的研發初期時,智財權團隊需扮演重要角色,協助研發人員並提供相關智財觀念,否則一種新藥開發至少需要 5-10年的研發期,若無法順利得到智財的保護,獲利將會大打折扣。影響活動的條件很多,但是現代人的時間寶貴,因此地點的選擇也就扮演著很重要的角色,國內搭乘高鐵南北往返開會已漸漸為趨勢。另一方面,同一次會議可得到最多的學分、技轉標的說明及課程內容,也將更容易吸引大眾前往參與的關鍵。 |
英文摘要 | Committee on Chinese Medicine and Pharmacy (CCMP) has excellent research projects results. Through this program, we not only assess the existing research results, but also select some good cases to obtain patent protection. Moreover we take positive actions to promote excellent research projects results and accelerate the application of research results and promote industrial development. Finally we arrange a committee to provide rich experience in patent and intellectual property commercialization, and provide consultative services related to services. METHOD: 1. To assist CCMP to assess and apply for patents, to hold open technology transfer and results applications which pharmaceutical, biotech companies etc., are invited. The willingness is to seek co-manufacturer, and to implement the industrialization of academic achievements. 2. To write investment, technology transfer and contracts information, and carry out patents and excellent research authorization. To arrange a team with intellectual property rights, patents ands technology transfer relevant experience to handle the results of the authorization., and to arrange a Committee for CCMP and moderators of CCMP research projects to consult. 3.To handle intellectual property rights of Chinese medicine-related courses. RESULTS: 1.We held four patent evaluation meetings in this CCMP plan. Less than 10% (2/21) cases meet requirements for patentability and could be applied for filing them in Taiwan. If necessary, these cases can also be claimed by a priority of Taiwan patent application to apply for foreign patents. 2. We took place some meeting to discuss technology transfer and application of the results open briefings (including technology transfer and intellectual rights briefings course). There are 240 people participated with a very active discussion and exchange of views. DISCUSSION: 1.Assessment of the case, the original plan for the 20, but in this case 22 assessment. Only 3 cases are qualified to meet the requirements for patentability, because most of cases lack novelty and inventive steps. Therefore, in future research and development in the early technology, intellectual property team needs to play an important role in helping researchers and providing the concept of intellectual property(included CCMP or SBIR , etc.,) As being a new drug development requires at least 5-10 years of R & D period, well-protected intellectual property protection will reduce profit from the intellectual property. 2.Some factors and conditions affect the activity of person to join a meeting. So, the choice of location also plays an important role. In particular, the factors include available credit, the subject of technology transfer instructions and course content. All above feature will be easier to attract the public to participate the meeting. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。